Holdings of Biotechnology Fund
Rydex Series Funds · Original filing · Compare with another fund · Report an error
- Net assets
- 136.8M $ including 136.3M $ in equities, 99.6 %
- Positions
- 70 in 9 countries
- Top ten
- 36.2 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 44,415 | 11.2M $ | 8.17 % |
| 2 | Amgen Inc | 19,065 | 6.9M $ | 5.05 % |
| 3 | Gilead Sciences Inc | 48,654 | 6.1M $ | 4.49 % |
| 4 | Vertex Pharmaceuticals Inc | 11,897 | 5.9M $ | 4.32 % |
| 5 | Regeneron Pharmaceuticals Inc | 6,432 | 4M $ | 2.93 % |
| 6 | REVOLUTION MEDICINES INC | 18,109 | 3.4M $ | 2.48 % |
| 7 | ALNYLAM PHARMACEUTICALS INC | 10,721 | 3.2M $ | 2.36 % |
| 8 | BEONE MEDICINES LTD | 10,427 | 3M $ | 2.17 % |
| 9 | MODERNA INC | 41,976 | 2.9M $ | 2.15 % |
| 10 | Biogen Inc | 13,465 | 2.9M $ | 2.13 % |
| 11 | NATERA INC | 10,672 | 2.9M $ | 2.12 % |
| 12 | ROYALTY PHARMA PLC | 49,095 | 2.8M $ | 2.01 % |
| 13 | Illumina Inc | 15,058 | 2.6M $ | 1.94 % |
| 14 | Insmed Inc | 22,998 | 2.5M $ | 1.79 % |
| 15 | United Therapeutics Corp | 4,350 | 2.4M $ | 1.72 % |
| 16 | GUARDANT HEALTH INC | 15,671 | 2.4M $ | 1.72 % |
| 17 | Roivant Sciences Ltd | 64,115 | 2.3M $ | 1.66 % |
| 18 | Incyte Corp | 19,518 | 2.2M $ | 1.62 % |
| 19 | VIATRIS INC | 133,745 | 2.1M $ | 1.55 % |
| 20 | Neurocrine Biosciences Inc | 12,363 | 2.1M $ | 1.52 % |
| 21 | Argenx SE | 2,181 | 2M $ | 1.48 % |
| 22 | JAZZ PHARMACEUTICALS PLC | 8,037 | 1.9M $ | 1.42 % |
| 23 | Bridgebio Pharma Inc | 25,399 | 1.9M $ | 1.38 % |
| 24 | IONIS PHARMACEUTICALS INC | 23,328 | 1.8M $ | 1.35 % |
| 25 | CYTOKINETICS INC | 21,687 | 1.8M $ | 1.35 % |
| 26 | Exelixis Inc | 33,461 | 1.8M $ | 1.33 % |
| 27 | Alkermes PLC | 34,306 | 1.8M $ | 1.31 % |
| 28 | Arrowhead Pharmaceuticals Inc | 20,951 | 1.7M $ | 1.25 % |
| 29 | BioMarin Pharmaceutical Inc | 29,626 | 1.7M $ | 1.24 % |
| 30 | AstraZeneca PLC | 8,846 | 1.7M $ | 1.23 % |
| 31 | Halozyme Therapeutics Inc | 20,474 | 1.6M $ | 1.17 % |
| 32 | BioNTech SE | 17,055 | 1.6M $ | 1.16 % |
| 33 | CRISPR Therapeutics AG | 29,038 | 1.6M $ | 1.16 % |
| 34 | VAXCYTE INC | 27,188 | 1.6M $ | 1.16 % |
| 35 | TG THERAPEUTICS INC | 27,004 | 1.5M $ | 1.08 % |
| 36 | Medpace Holdings Inc | 2,659 | 1.4M $ | 1.03 % |
| 37 | Apogee Therapeutics Inc | 10,512 | 1.4M $ | 1.02 % |
| 38 | COGENT BIOSCIENCES INC | 35,458 | 1.4M $ | 1.00 % |
| 39 | TWIST BIOSCIENCE CORP | 13,098 | 1.3M $ | 0.98 % |
| 40 | PTC Therapeutics Inc | 16,516 | 1.3M $ | 0.98 % |
| 41 | Scholar Rock Holding Corp | 24,468 | 1.3M $ | 0.98 % |
| 42 | Nuvalent Inc | 10,892 | 1.3M $ | 0.98 % |
| 43 | Axsome Therapeutics Inc | 5,367 | 1.3M $ | 0.96 % |
| 44 | CG ONCOLOGY INC | 18,440 | 1.3M $ | 0.96 % |
| 45 | Krystal Biotech Inc | 3,406 | 1.3M $ | 0.93 % |
| 46 | Viking Therapeutics Inc | 31,452 | 1.2M $ | 0.90 % |
| 47 | TRAVERE THERAPEUTICS INC | 21,589 | 1.2M $ | 0.90 % |
| 48 | Protagonist Therapeutics Inc | 9,900 | 1.2M $ | 0.89 % |
| 49 | Ascendis Pharma A/S | 4,546 | 1.2M $ | 0.89 % |
| 50 | Veracyte Inc | 20,449 | 1.2M $ | 0.88 % |
| 51 | Liquidia Corp | 14,813 | 1.2M $ | 0.86 % |
| 52 | KYMERA THERAPEUTICS INC | 9,937 | 1.1M $ | 0.83 % |
| 53 | Madrigal Pharmaceuticals Inc | 2,022 | 1.1M $ | 0.79 % |
| 54 | Ultragenyx Pharmaceutical Inc | 31,574 | 1.1M $ | 0.77 % |
| 55 | Beam Therapeutics Inc | 29,626 | 1M $ | 0.74 % |
| 56 | IMMUNITYBIO INC | 115,501 | 1M $ | 0.74 % |
| 57 | MIRUM PHARMACEUTICALS INC | 8,626 | 1M $ | 0.74 % |
| 58 | Praxis Precision Medicines Inc | 2,953 | 988.6K $ | 0.72 % |
| 59 | Rhythm Pharmaceuticals Inc | 8,809 | 978.1K $ | 0.71 % |
| 60 | ACADIA Pharmaceuticals Inc | 38,546 | 975.2K $ | 0.71 % |
| 61 | Intellia Therapeutics Inc | 52,464 | 887.7K $ | 0.65 % |
| 62 | Arcutis Biotherapeutics Inc | 32,799 | 860K $ | 0.63 % |
| 63 | Recursion Pharmaceuticals Inc | 203,986 | 748.6K $ | 0.55 % |
| 64 | SAREPTA THERAPEUTICS INC | 41,327 | 742.6K $ | 0.54 % |
| 65 | Summit Therapeutics Inc | 49,916 | 727.3K $ | 0.53 % |
| 66 | LEGEND BIOTECH CORP | 23,843 | 688.6K $ | 0.50 % |
| 67 | ADMA Biologics Inc | 82,224 | 688.2K $ | 0.50 % |
| 68 | Celcuity Inc | 5,918 | 619.1K $ | 0.45 % |
| 69 | GRAIL Inc | 7,633 | 521.1K $ | 0.38 % |
| 70 | Akero Therapeutics Inc | 17,387 | 1.7 $ |
Sector breakdown
- Health care 46.6 %
- Unattributed 53.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 89.2 %
- Ireland 2.7 %
- Bermuda 1.7 %
- Netherlands 1.5 %
- United Kingdom 1.2 %
- Germany 1.2 %
- Switzerland 1.2 %
- Denmark 0.9 %
- Cayman Islands 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 61 | 121.5M $ | 89.16 % |
| 2 | Ireland | 2 | 3.7M $ | 2.74 % |
| 3 | Bermuda | 1 | 2.3M $ | 1.67 % |
| 4 | Netherlands | 1 | 2M $ | 1.48 % |
| 5 | United Kingdom | 1 | 1.7M $ | 1.23 % |
| 6 | Germany | 1 | 1.6M $ | 1.16 % |
| 7 | Switzerland | 1 | 1.6M $ | 1.16 % |
| 8 | Denmark | 1 | 1.2M $ | 0.89 % |
| 9 | Cayman Islands | 1 | 688.6K $ | 0.51 % |
Cite this page
Titelia. "Holdings of Biotechnology Fund". https://titelia.com/en/funds/S000003802